Powder: -20°C for 3 years | In solvent: -80°C for 1 year
3-Deazaadenosine is an inhibitor of S-adenosylhomocysteine hydrolase, with a Ki of 3.9 μM, and it has anti-inflammatory, anti-proliferative and anti-HIV activity.
产品描述 | 3-Deazaadenosine is an inhibitor of S-adenosylhomocysteine hydrolase, with a Ki of 3.9 μM, and it has anti-inflammatory, anti-proliferative and anti-HIV activity. |
靶点活性 | HIV-1 (A018 isolate):0.20 μM, HIV-1 (A012 isolate):0.15, S-adenosylhomocysteine hydrolase:(ki)3.9 μM |
体外活性 | 3-Deazaadenosine is an inhibitor of S-adenosylhomocysteine hydrolase, with a Ki of 3.9 μM. 3-Deazaadenosine shows anti-HIV effect, and inhibits p24 antigen in peripheral blood mononuclear (PBMCs) cells infected with HIV-1 isolates (A012 and A018) with IC50s of 0.15 and 0.20 μM, respectively[1]. 3-Deazaadenosine (100 μM) enhances nuclear translocation of NF-κB, but blocks LPS-induced NF-κB transcriptional activity, and such inhibition is augmented by the addition of homocysteine[2]. 3-Deazaadenosine (50 μM) suppresses vascular smooth muscle cell (VSMC) proliferation via interfering with Ras signaling[3]. 3-Deazaadenosine (50, 100 μM) dose-dependently inhibits the phosphorylation of Raf and ERK, protein-dependent kinase 1, protein kinase B (Akt), and forkhead transcription factor FoxO1a. 3-Deazaadenosine (1-100 μM) inhibits LPS-induced expression of TNF-α mRNA, increases DNA binding activity of NF-κB, and causes proteolytic degradation of IκBα, but Not IκBβ in RAW 264.7 cells. |
分子量 | 266.25 |
分子式 | C11H14N4O4 |
CAS No. | 6736-58-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 130 mg/mL (488.26 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.7559 mL | 18.7793 mL | 37.5587 mL | 93.8967 mL |
5 mM | 0.7512 mL | 3.7559 mL | 7.5117 mL | 18.7793 mL | |
10 mM | 0.3756 mL | 1.8779 mL | 3.7559 mL | 9.3897 mL | |
20 mM | 0.1878 mL | 0.939 mL | 1.8779 mL | 4.6948 mL | |
50 mM | 0.0751 mL | 0.3756 mL | 0.7512 mL | 1.8779 mL | |
100 mM | 0.0376 mL | 0.1878 mL | 0.3756 mL | 0.939 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
3-Deazaadenosine 6736-58-9 Microbiology/Virology Proteases/Proteasome HIV Protease 3 Deazaadenosine 3Deazaadenosine Inhibitor inhibitor inhibit